Naveen Pemmaraju: Delighted to share our brand new review paper led by Dr Hannah Goulart

Naveen Pemmaraju recently shared a post on X:

“Delighted to share our brand new review paper at the British Journal of Haematology led by Dr Hannah Goulart.”

Read further
Source: Naveen Pemmaraju/X

Naveen Pemmaraju is a Professor and Director of the BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of the MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.